Announce Date | 02/13/2025 |
EPS Normalized Actual | $2.38 (Beat by $0.1) |
EPS GAAP Actual | $2.38 (Beat by $0.1) |
Revenue Actual | $7.166B |
Revenue Surprise | Beat by $7166M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Oct 2028 | 12.65395 | 10.03 | 11.31284 | 13.75844 | 4 |
Oct 2027 | 11.95 | 10.62 | 11.26144 | 12.72679 | 3 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Jan 2025) | 1.46 | 1.46 | 7.166B | 6.41% | 7166M |
FQ4 2024 (Oct 2024) | 2.11 | 2.11 | 7.045B | 4.57% | 7045M |
FQ3 2024 (Jul 2024) | 2.06 | 2.06 | 6.778B | 5.21% | 6778M |
FQ2 2024 (Apr 2024) | 2.07 | 2.07 | 6.646B | 100% | 6646M |
FQ1 2024 (Jan 2024) | 2.43 | 2.43 | 6.707B | -0.48% | 6707M |
FQ4 2023 (Oct 2023) | 2.4 | 2.4 | 6.723B | -0.39% | 6723M |
FQ3 2023 (Jul 2023) | 1.86 | 1.86 | 6.425B | -1.48% | 6425M |
FQ1 2023 (Jan 2023) | 2.03 | 2.03 | 6.739B | 100% | 6739M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Oct 2027) | 2.86305 | -- | 2.83301 | 2.95311 | 18 |
FQ3 2027 (Jul 2027) | 2.82434 | -- | 2.7947 | 2.91318 | 15 |
FQ2 2027 (Apr 2027) | 2.76375 | -- | 2.73475 | 2.85069 | 12 |
FQ1 2027 (Jan 2027) | 2.70161 | -- | 2.67364 | 2.78698 | 13 |
FQ4 2026 (Oct 2026) | 2.66705 | -- | 2.63906 | 2.75095 | 12 |
FQ3 2026 (Jul 2026) | 2.3353 | -- | 2.26452 | 2.46861 | 6 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Oct 2027) | 8.47B | -- | 8.4B | 8.68B | 12 |
FQ3 2027 (Jul 2027) | 8.41B | -- | 8.34B | 8.61B | 13 |
FQ2 2027 (Apr 2027) | 8.26B | -- | 8.19B | 8.46B | 12 |
FQ1 2027 (Jan 2027) | 8.01B | -- | 7.95B | 8.21B | 12 |
FQ4 2026 (Oct 2026) | 7.93B | -- | 7.86B | 8.12B | 12 |
FQ3 2026 (Jul 2026) | 7.48B | -- | 7.3B | 7.8B | 7 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Jan 2025) | 1.46 | 1.46 | 100% | |
FQ4 2024 (Oct 2024) | 2.11 | 2.11 | 100% | |
FQ3 2024 (Jul 2024) | 2.06 | 2.06 | 100% | |
FQ2 2024 (Apr 2024) | 2.07 | 2.07 | 100% | |
FQ1 2024 (Jan 2024) | 2.43 | 2.43 | 100% | |
FQ4 2023 (Oct 2023) | 2.4 | 2.4 | 100% | |
FQ3 2023 (Jul 2023) | 1.86 | 1.86 | 100% | |
FQ1 2023 (Jan 2023) | 2.03 | 2.03 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Jan 2025) | $0B | $7.17B | $7166M | 100% |
FQ4 2024 (Oct 2024) | $0B | $7.05B | $7045M | 100% |
FQ3 2024 (Jul 2024) | $0B | $6.78B | $6778M | 100% |
FQ2 2024 (Apr 2024) | $0B | $6.65B | $6646M | 100% |
FQ1 2024 (Jan 2024) | $0B | $6.71B | $6707M | 100% |
FQ4 2023 (Oct 2023) | $0B | $6.72B | $6723M | 100% |
FQ3 2023 (Jul 2023) | $0B | $6.43B | $6425M | 100% |
FQ1 2023 (Jan 2023) | $0B | $6.74B | $6739M | 100% |